Bank Of America Corp Leap Therapeutics, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.29 - $0.72 $2,024 - $5,027	-6,982 Reduced 97.13%	206 $0
Q4 2022 Feb 10, 2023	SELL	$0.42 - $9.18 $23,834 - $520,955	-56,749 Reduced 88.76%	7,188 $3,000
Q3 2022 Nov 14, 2022	SELL	$0.92 - $9.3 $165,182 - $1.67 Million	-179,546 Reduced 73.74%	63,937 $56,000
Q2 2022 Aug 12, 2022	SELL	$0.96 - $1.91 $568,744 - $1.13 Million	-592,442 Reduced 70.87%	243,483 $280,000
Q1 2022 May 16, 2022	SELL	$1.6 - $3.35 $1,844 - $3,862	-1,153 Reduced 0.14%	835,925 $1.46 Million
Q4 2021 Feb 08, 2022	BUY	$2.08 - $3.65 $216,459 - $379,844	104,067 Added 14.2%	837,078 $2.71 Million
Q3 2021 Nov 15, 2021	BUY	$1.35 - $4.01 $988,957 - $2.94 Million	732,561 Added 162791.33%	733,011 $2.94 Million
Q2 2021 Sep 13, 2021	BUY	$1.48 - $1.92 $666 - $864	450 New	450 $1,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $239M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.